
Christopher W. Farnsworth, PhD
Professor, Pathology & Immunology
Contact
- Email: cwfarnsworth@wustl.edu
- Phone: 314-362-1503
Titles
Section Head, Clinical Chemistry
Co-Director, Clinical Chemistry Fellowship
Medical Director, Clinical Chemistry, Barnes Jewish Hospital
Medical Director, Point of Care testing, Barnes Jewish Hospital
Education
PhD: Pathology, University of Rochester, Rochester, NY (2017)
Fellowship, Clinical Chemistry: Washington University School of Medicine, St. Louis, MO (2019)
Recognition
Ellis Benson Award. Academy of Clinical Laboratory Physicians and Scientists (2024)
Paul E. Strandjord Young Investigator Award. Academy of Clinical Laboratory Physicians and Scientists annual meeting. Salt Lake City, UT (2019)
Runner Up, Best-oral presentation. American Association for Clinical Chemistry annual meeting. Anaheim, CA (2019)
Outstanding Achievements in Leadership and Professionalism Award, Washington University Department of Pathology & Immunology (2020)
Special Recognition Award, nominated for development of SARS-CoV-2 testing. Washington University Department of Pathology & Immunology (2020)
Distinguished Abstract Award, 2021 AACC Annual Meeting (2021)
George Grannis Award for Excellence in Research and Scientific Publication. AACC Academy (2021)
BJC Team Award for Quality Improvement (TAQI): Reducing Quantity Not Sufficient Specimens (2021)
Outstanding Scientific Achievements by a Young Investigator, AACC (2022)
Outstanding Clinical Paper of the Year, Washington University Department of Pathology & Immunology (2022)
Research Interests
My research aims to improve patient care by refining, discovering, and implementing biomarkers for the detection and prediction of disease, particularly in acute and critical care settings. My specific interests include the use of biomarkers to aid in the diagnosis and prognostication of infectious disease including sepsis and viral infections. I am also interested in the use of cardiac biomarkers as a measure of cardiotoxicity in both the acute and chronic care settings. Finally, I am interested in the preanalytical phase of testing and identifying variables that impact laboratory results.
Selected Publications
Estimated waste generation from 1 million basic metabolic panels: a multisite U.S. study
Publication
Evaluation of three NT-proBNP assays for heart failure
Publication
Commentary on Abnormal Thyroid Function Test in a Patient Taking Carbamazepine
Publication
SARS-CoV-2 PCR and antibody positivity in asymptomatic health care workers with a known SARS-CoV-2 exposure: December, 2020 to December, 2021
Publication
Assistant
